This company has been marked as potentially delisted and may not be actively trading. GX Acquisition (GXGX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock GXGX vs. VSTM, ABEO, RCKT, AQST, TRDA, HRTX, TERN, TNXP, NGNE, and CYRXShould you be buying GX Acquisition stock or one of its competitors? The main competitors of GX Acquisition include Verastem (VSTM), Abeona Therapeutics (ABEO), Rocket Pharmaceuticals (RCKT), Aquestive Therapeutics (AQST), Entrada Therapeutics (TRDA), Heron Therapeutics (HRTX), Terns Pharmaceuticals (TERN), Tonix Pharmaceuticals (TNXP), Neurogene (NGNE), and Cryoport (CYRX). GX Acquisition vs. Its Competitors Verastem Abeona Therapeutics Rocket Pharmaceuticals Aquestive Therapeutics Entrada Therapeutics Heron Therapeutics Terns Pharmaceuticals Tonix Pharmaceuticals Neurogene Cryoport Verastem (NASDAQ:VSTM) and GX Acquisition (NASDAQ:GXGX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, community ranking, dividends and earnings. Is VSTM or GXGX more profitable? Verastem's return on equity of -332.73% beat GX Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets VerastemN/A -332.73% -73.97% GX Acquisition N/A -985.20%-6.02% Does the MarketBeat Community prefer VSTM or GXGX? Verastem received 617 more outperform votes than GX Acquisition when rated by MarketBeat users. However, 100.00% of users gave GX Acquisition an outperform vote while only 65.36% of users gave Verastem an outperform vote. CompanyUnderperformOutperformVerastemOutperform Votes61965.36% Underperform Votes32834.64% GX AcquisitionOutperform Votes2100.00% Underperform VotesNo Votes Which has preferable valuation and earnings, VSTM or GXGX? GX Acquisition has lower revenue, but higher earnings than Verastem. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVerastem$10M30.77-$87.37M-$3.20-1.75GX AcquisitionN/AN/A-$49.26MN/AN/A Do analysts recommend VSTM or GXGX? Verastem presently has a consensus price target of $13.63, suggesting a potential upside of 143.30%. Given Verastem's stronger consensus rating and higher possible upside, analysts plainly believe Verastem is more favorable than GX Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Verastem 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 3.00GX Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer VSTM or GXGX? In the previous week, Verastem had 1 more articles in the media than GX Acquisition. MarketBeat recorded 1 mentions for Verastem and 0 mentions for GX Acquisition. Verastem's average media sentiment score of 1.87 beat GX Acquisition's score of 0.00 indicating that Verastem is being referred to more favorably in the media. Company Overall Sentiment Verastem Very Positive GX Acquisition Neutral Which has more volatility & risk, VSTM or GXGX? Verastem has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, GX Acquisition has a beta of 0.17, suggesting that its stock price is 83% less volatile than the S&P 500. Do insiders and institutionals believe in VSTM or GXGX? 88.4% of Verastem shares are held by institutional investors. Comparatively, 61.7% of GX Acquisition shares are held by institutional investors. 2.1% of Verastem shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryVerastem beats GX Acquisition on 11 of the 14 factors compared between the two stocks. Get GX Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for GXGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GXGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GXGX vs. The Competition Export to ExcelMetricGX AcquisitionPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$62.89M$6.88B$5.57B$8.51BDividend YieldN/A2.51%5.27%4.15%P/E RatioN/A8.5026.7819.65Price / SalesN/A263.11404.49152.18Price / CashN/A65.8538.2534.64Price / Book12.506.526.964.59Net Income-$49.26M$143.48M$3.23B$248.23M GX Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GXGXGX AcquisitionN/A$1.75-0.6%N/A-45.7%$62.89MN/A0.00N/AGap DownVSTMVerastem3.4707 of 5 stars$5.90-2.0%$13.63+130.9%+53.0%$324.20M$10M-1.8550High Trading VolumeABEOAbeona Therapeutics4.0761 of 5 stars$6.27-0.2%$19.25+207.0%+34.2%$320.75M$3.50M-2.33N/AAnalyst RevisionRCKTRocket Pharmaceuticals4.9487 of 5 stars$2.96+6.9%$19.57+561.2%-87.2%$316.09MN/A-1.08240Trending NewsAnalyst RevisionGap DownHigh Trading VolumeAQSTAquestive Therapeutics1.6842 of 5 stars$3.18+13.2%$10.14+219.0%+23.5%$315.86M$54.23M-7.07160Positive NewsAnalyst RevisionTRDAEntrada Therapeutics2.9076 of 5 stars$8.24+1.2%$25.67+211.5%-53.9%$312.73M$172.22M5.18110Positive NewsAnalyst DowngradeGap DownHRTXHeron Therapeutics3.8707 of 5 stars$2.00+3.6%$5.50+175.0%-46.9%$305.13M$148.52M-11.11300Analyst RevisionTERNTerns Pharmaceuticals4.1215 of 5 stars$3.49+6.4%$15.63+347.7%-51.4%$304.81MN/A-2.9640Positive NewsTNXPTonix Pharmaceuticals3.3336 of 5 stars$40.45+6.3%$585.00+1,346.2%-70.7%$296.30M$10.04M-0.0150Trending NewsGap DownNGNENeurogene3.4784 of 5 stars$20.56+15.8%$44.60+116.9%-52.9%$293.23M$925K-4.7390News CoverageAnalyst ForecastGap DownCYRXCryoport3.4085 of 5 stars$5.84+8.1%$11.00+88.4%-35.5%$292.80M$232.13M-1.731,020Trending NewsInsider TradeGap Down Related Companies and Tools Related Companies VSTM Competitors ABEO Competitors RCKT Competitors AQST Competitors TRDA Competitors HRTX Competitors TERN Competitors TNXP Competitors NGNE Competitors CYRX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GXGX) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GX Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GX Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.